Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Amanda Bronstad | December 15, 2023
OptumRx, a pharmacy benefit manager facing trials over its role in the opioid crisis, has moved to disqualify Motley Rice, citing alleged ethical violations tied to confidential information the law firm received through government subpoenas.
5 minute read
By Amanda Bronstad | December 15, 2023
OptumRx, a pharmacy benefit manager facing trials over its role in the opioid crisis, has moved to disqualify Motley Rice, citing alleged ethical violations tied to confidential information the law firm received through government subpoenas.
5 minute read
By Brian Lee | December 14, 2023
An attorney for a New York consumer-protection advocacy coalition asked lawmakers to advance a fifth proposal, the Consumer and Small Business Protection Act, which didn't make it out of committee.
3 minute read
By Colleen Murphy | December 13, 2023
"Merck later admitted its lawsuit had no merit because it had failed to disclose prior art to the United States Patent and Trademark Office that would have resulted in the denial of patent protection for Zetia," the complaint said. "But simply by initiating the litigation, Merck triggered a 30-month stay, which precluded the Food & Drug Administration from granting final approval of Glenmark's ANDA."
3 minute read
By Jimmy Hoover | December 13, 2023
The Supreme Court, which sought to "return the issue of abortion" to the states back in 2022, is set once again to wade into the battle over reproductive rights by hearing an appeal to reinstate full access to the abortion pill.
5 minute read
By Riley Brennan | December 12, 2023
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be first to know about new suits in your region, practice area or client sector.
5 minute read
By Amanda Bronstad | December 11, 2023
Peter Mougey, a lead plaintiffs attorney in the opioid multidistrict litigation, said of Suboxone patients: "Their teeth are falling out of their mouths."
5 minute read
By Karen Hoffman Lent and Kenneth Schwartz | December 11, 2023
Antitrust developments in the health care and pharmaceutical industries were exceptionally active in 2023. From the FTC's challenge of a merger between Amgen and Horizon Therapeutics, to joint agency withdrawal of well-established health care merger policy statements, to agency interest in pharmacy benefit managers, the authors review some of the most notable antitrust activity in the health care and pharmaceutical industries over the past year.
10 minute read
By Jimmy Hoover | December 4, 2023
High court members note opioid victims' broad support for the deal despite the federal government's objection.
5 minute read
By Adolfo Pesquera | November 21, 2023
The attorney general alleges in the complaints that, "Pfizer knowingly distributed Quillivant to children on Medicaid despite the drug's pattern of failing quality control tests due to flawed manufacturing practices."
3 minute read
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS